{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:03:30Z","timestamp":1790975010903,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Fondo de Investigacion en Salud (FIS), Instituto Mexicano del Seguro Social","award":["FIS\/IMSS\/PROT\/MD15\/1505"],"award-info":[{"award-number":["FIS\/IMSS\/PROT\/MD15\/1505"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Irisin stimulates osteoblast differentiation increasing bone mass a decreasing in irisin levels might contribute to osteoporotic fractures in inflammatory diseases. To date, there is controverted whether irisin levels are associated with osteoporotic fractures in rheumatoid arthritis (RA). Therefore, we evaluate the association of serum irisin with osteoporotic Vertebral Fractures (VFs) in women with RA.<\/jats:p>\n            <jats:p>A total of 148 women with RA was included in the study.<\/jats:p>\n            <jats:p>Clinical characteristics and risk factors of VFs was evaluated. For measurement of bone mineral density we included the assessment of lumbar spine (AP L1-L4) and Femoral Neck by dual-energy X-ray absorptiometry (DXA). VFs were evaluated by lateral vertebral assessment (LVA) of the dorsal and lumbar regions using X-ray and digital vertebral morphometry by DXA, using the Genant scale. Serum irisin levels were measured by ELISA. A reference group of 97 women with non-rheumatic diseases were included to compare irisin levels.<\/jats:p>\n            <jats:p>RA patients had a median age of 59\u200ayears and 41% had osteoporosis. Seventy three (49%) had VFs. Lower irisin levels were observed in RA patients compared to controls (94\u200a\u00b1\u200a74 vs 135\u200a\u00b1\u200a103, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Irisin concentrations were lower in RA\u200a+\u200aVFs than RA non-VFs (74\u200a\u00b1\u200a42 vs 113\u200a\u00b1\u200a92\u200ang\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001). In the multivariable logistic regression analysis the low 50 percentile irisin levels\u200a&lt;\u200a73\u200ang\/mL (OR:3.1, 95% CI:1.55\u20136.2, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001), and disease duration of RA (OR:1.04, 95% CI:1.001\u20131.08, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.04) were associated with an increase in the risk of VFs.<\/jats:p>\n            <jats:p>A decrease of irisin levels is associated to VFs in RA. These results are valuable to consider that RA patients with low levels of irisin are in a potential risk of VFs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028799","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T13:02:09Z","timestamp":1644584529000},"page":"e28799","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Serum irisin concentrations and osteoporotic vertebral fractures in women with rheumatoid arthritis"],"prefix":"10.1097","volume":"101","author":[{"given":"Jorge Ivan","family":"Gamez-Nava","sequence":"first","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"},{"name":"Unidad de Investigaci\u00f3n Biom\u00e9dica 02, UMAE, Hospital de Especialidades, Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Ramirez-Villafa\u00f1a","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n Biom\u00e9dica 02, UMAE, Hospital de Especialidades, Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, M\u00e9xico"},{"name":"Programa de Doctorado en Ciencias M\u00e9dicas, Universidad de Colima, Colima, Colima, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidencio","family":"Cons-Molina","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n en Artritis y Osteoporosis, Mexicali , Baja California, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli Efrain","family":"Gomez-Ramirez","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yussef","family":"Esparza-Guerrero","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Miriam","family":"Salda\u00f1a-Cruz","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Nerida","family":"Sanchez-Rodriguez","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heriberto","family":"Jacobo-Cuevas","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia Elena","family":"Totsuka-Sutto","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edsaul Emilio","family":"Perez-Guerrero","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Huerta","sequence":"additional","affiliation":[{"name":"Centro Universitario de Investigaciones Biom\u00e9dicas (CUIB), Universidad de Colima, Colima, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xochitl","family":"Trujillo","sequence":"additional","affiliation":[{"name":"Centro Universitario de Investigaciones Biom\u00e9dicas (CUIB), Universidad de Colima, Colima, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Clemente","family":"Vasquez-Jimenez","sequence":"additional","affiliation":[{"name":"Centro Universitario de Investigaciones Biom\u00e9dicas (CUIB), Universidad de Colima, Colima, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulfo Hernan","family":"Nava-Zavala","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n Biom\u00e9dica 02, UMAE, Hospital de Especialidades, Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, M\u00e9xico"},{"name":"Programa Internacional de Medicina, Universidad Aut\u00f3noma de Guadalajara, Zapopan, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto German","family":"Cardona-Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6441-8997","authenticated-orcid":false,"given":"Miriam Fabiola","family":"Alcaraz-Lopez","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Interna-Reumatolog\u00eda, Hospital General Regional 46 and Hospital General Regional 110; IMSS, Guadalajara, Jalisco, M\u00e9xico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-6344","authenticated-orcid":false,"given":"Laura","family":"Gonzalez-Lopez","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas, Programa de Doctorado en Salud Publica, Departamento de Salud Publica, Programa de Doctorado en Farmacolog\u00eda, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"},{"name":"Departamento de Medicina Interna-Reumatolog\u00eda, Hospital General Regional 46 and Hospital General Regional 110; IMSS, Guadalajara, Jalisco, M\u00e9xico."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00296-017-3769-3","article-title":"Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis","volume":"37","author":"Galarza-Delgado","year":"2017","journal-title":"Rheumatol Int"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3899\/jrheum.110467","article-title":"Performance of risk indices for identifying low bone mineral density and osteoporosis in Mexican Mestizo women with rheumatoid arthritis","volume":"39","author":"Gonzalez-Lopez","year":"2012","journal-title":"J Rheumatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/rheumatology\/keu162","article-title":"Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis","volume":"53","author":"Hauser","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3899\/jrheum.121493","article-title":"(2014) Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study","volume":"40","author":"Amin","year":"2013","journal-title":"J Rheumatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/keq084","article-title":"Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment","volume":"49","author":"El Maghraoui","year":"2010","journal-title":"Rheumatology (Oxford"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/ket353","article-title":"The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis","volume":"53","author":"Mohammad","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11739-018-1874-2","article-title":"Guidelines for the management of osteoporosis and fragility fractures","volume":"14","author":"Nuti","year":"2019","journal-title":"Intern Emerg Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"902186","DOI":"10.1155\/2014\/902186","article-title":"Irisin enhances osteoblast differentiation in vitro","volume":"2014","author":"Colaianni","year":"2014","journal-title":"Int J Endocrinol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"16056","DOI":"10.1038\/boneres.2016.56","article-title":"Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism","volume":"5","author":"Zhang","year":"2017","journal-title":"Bone Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.peptides.2018.03.018","article-title":"An update on the role of irisin in the regulation of endocrine and metabolic functions","volume":"104","author":"Mahgoub","year":"2018","journal-title":"Peptides"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12020-017-1476-1","article-title":"Irisin in metabolic diseases","volume":"59","author":"Polyzos","year":"2018","journal-title":"Endocrine"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1073\/pnas.1516622112","article-title":"The myokine irisin increases cortical bone mass","volume":"112","author":"Colaianni","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e100218","DOI":"10.1371\/journal.pone.0100218","article-title":"Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and strength estimates","volume":"9","author":"Singhal","year":"2014","journal-title":"PLoS One"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00198-014-2673-x","article-title":"Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months","volume":"25","author":"Anastasilakis","year":"2014","journal-title":"Osteoporos Int"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/cen.12672","article-title":"Irisin is associated with osteoporotic fractures independently of bone mineral density,1 body composition or daily physical activity","volume":"82","author":"Palermo","year":"2015","journal-title":"Clin Endocrinol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jbspin.2017.03.011","article-title":"Low serum concentrations of irisin are associated with increased risk of hip fracture in Chinese older women","volume":"85","author":"Yan","year":"2018","journal-title":"Joint Bone Spine"},{"key":"R17-20250504","first-page":"702","article-title":"Irisin as a new marker for the early diagnosis of low-traumatic fractures in rheumatoid arthritis","volume":"63","author":"Lavrova","year":"2018","journal-title":"Klin Lab Diagn"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"(5 Suppl 39)","key":"R20-20250504","first-page":"S93","article-title":"The disease activity score and the EULAR response criteria","volume":"23","author":"Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R21-20250504","first-page":"117","article-title":"How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-Di)","volume":"11","author":"Cardiel","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"R23-20250504","first-page":"137","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2017-eular.2040","article-title":"AB0349-the serum level of irisin is decreased in the patients with rheumatoid arthritis [abstract]","volume":"76","author":"Kalkan","year":"2017","journal-title":"Ann Rheumat Dis"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-011-1584-3","article-title":"Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids","volume":"23","author":"Ghazi","year":"2012","journal-title":"Osteoporos Int"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jocd.2010.04.003","article-title":"Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation","volume":"13","author":"Gertz","year":"2010","journal-title":"J Clin Densitom"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:02:40Z","timestamp":1746331360000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028799"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028799","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"2021-02-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}